Year |
Citation |
Score |
2011 |
Bottone FG, Alston-Mills B. The dietary compounds resveratrol and genistein induce activating transcription factor 3 while suppressing inhibitor of DNA binding/differentiation-1. Journal of Medicinal Food. 14: 584-93. PMID 21554132 DOI: 10.1089/Jmf.2010.0110 |
0.693 |
|
2007 |
Lee CR, Bottone FG, Krahn JM, Li L, Mohrenweiser HW, Cook ME, Petrovich RM, Bell DA, Eling TE, Zeldin DC. Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). Pharmacogenetics and Genomics. 17: 145-60. PMID 17301694 DOI: 10.1097/01.Fpc.0000236340.87540.E3 |
0.395 |
|
2005 |
Moon Y, Bottone FG, McEntee MF, Eling TE. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Molecular Cancer Therapeutics. 4: 1551-8. PMID 16227405 DOI: 10.1158/1535-7163.Mct-05-0213 |
0.599 |
|
2005 |
Kim JS, Baek SJ, Bottone FG, Sali T, Eling TE. Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells. Molecular Cancer Research : McR. 3: 511-7. PMID 16179498 DOI: 10.1158/1541-7786.Mcr-05-0011 |
0.479 |
|
2005 |
Bottone FG, Moon Y, Alston-Mills B, Eling TE. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene. The Journal of Pharmacology and Experimental Therapeutics. 315: 668-77. PMID 16079301 DOI: 10.1124/Jpet.105.089607 |
0.681 |
|
2005 |
Bottone FG, Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Molecular Cancer Therapeutics. 4: 693-703. PMID 15897233 DOI: 10.1158/1535-7163.Mct-04-0337 |
0.698 |
|
2005 |
Ishibashi M, Bottone FG, Taniura S, Kamitani H, Watanabe T, Eling TE. The cyclooxygenase inhibitor indomethacin modulates gene expression and represses the extracellular matrix protein laminin gamma1 in human glioblastoma cells. Experimental Cell Research. 302: 244-52. PMID 15561105 DOI: 10.1016/J.Yexcr.2004.09.021 |
0.598 |
|
2004 |
Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 70: 7-15. PMID 14643174 DOI: 10.1016/J.Plefa.2003.06.001 |
0.46 |
|
2004 |
Bottone FG, Martinez JM, Alston-Mills B, Eling TE. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis. 25: 349-57. PMID 14633654 DOI: 10.1093/Carcin/Bgh016 |
0.676 |
|
2003 |
Bottone FG, Martinez JM, Collins JB, Afshari CA, Eling TE. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. The Journal of Biological Chemistry. 278: 25790-801. PMID 12734198 DOI: 10.1074/jbc.M301002200 |
0.582 |
|
2002 |
Bottone FG, Baek SJ, Nixon JB, Eling TE. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. The Journal of Nutrition. 132: 773-8. PMID 11925476 DOI: 10.1093/Jn/132.4.773 |
0.497 |
|
Show low-probability matches. |